ROYAL BANK OF CANADA - INTELLIPHARMACEUTICS INTL IN ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q2 2018$7,000
-22.2%
16,446
+3.5%
0.00%
Q1 2018$9,000
-30.8%
15,894
-2.0%
0.00%
Q4 2017$13,00016,214
+135016.7%
0.00%
Q3 2017$0
-100.0%
12
-98.0%
0.00%
Q2 2017$1,0000.0%596
-16.2%
0.00%
Q1 2017$1,000
-50.0%
711
+18.9%
0.00%
Q4 2016$2,000
+100.0%
5980.0%0.00%
Q3 2016$1,000
-98.6%
598
-98.7%
0.00%
Q2 2016$72,000
+7100.0%
46,098
+7608.7%
0.00%
Q1 2016$1,000
-50.0%
598
-33.5%
0.00%
Q4 2015$2,0000.0%899
-0.8%
0.00%
Q3 2015$2,000
+100.0%
906
+195.1%
0.00%
Q2 2015$1,0000.0%307
-0.3%
0.00%
Q1 2015$1,0000.0%308
+2.0%
0.00%
Q4 2014$1,000302
+30100.0%
0.00%
Q3 2014$01
-98.6%
0.00%
Q2 2014$069
+1625.0%
0.00%
Q1 2014$040.0%0.00%
Q4 2013$040.0%0.00%
Q3 2013$040.0%0.00%
Q2 2013$040.00%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q3 2018
NameSharesValueWeighting ↓
FIRST FOUNDATION ADVISORS 274,592$686,0000.04%
Argent Trust Co 39,137$98,0000.04%
Acrospire Investment Management LLC 10,777$27,0000.02%
SABBY MANAGEMENT, LLC 20,412$51,0000.00%
HL FINANCIAL SERVICES LLC 33,000$83,0000.00%
Advisor Group, Inc. 30,067$75,0000.00%
Financial Architects, Inc 1,100$3,0000.00%
BANK OF MONTREAL /CAN/ 245,800$615,0000.00%
DEUTSCHE BANK AG\ 305,807$763,0000.00%
BANK OF AMERICA CORP /DE/ 16$00.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders